Acuamark Diagnostics Secures $11.3 Million Series A Funding to Advance Innovative Assays for Improved, Cost-Effective Early-Cancer Detection
(Adnkronos) - The round was led by Claudio Del Vecchio and joined by Bruker Corporation.
NEW YORK, July 20, 2022 /PRNewswire/ -- Acuamark Diagnostics ("AcuamarkDx"), an early cancer detection company, today announced the closing of an $11.3 million Series A round.
The round was led by the office of Claudio Del Vecchio